Your Acute Myeloid Leukemia (AML) diagnosis is just a starting point. Even though the path ahead may seem unclear or even insurmountable, armed with knowledge you can take control.
Let us help you become empowered to understand your diagnosis, to confidently ask questions, and to identify providers that are the best fit for you.
We are here to help you move from crisis to action. Visit our resources to find the insight you need to take control today.
Articles & Resources
Elevate | AML Resource Guide
/in Acute Myeloid Leukemia, AML Elevate, AML Elevate Guides, AML Newly Diagnosed, AML Programs, AML Resource ND, AML Resources TC, AML Treatment & Clinical Trials, AML Treatment & Clinical Trials Guide, AML Treatments and Clinical Trials, ELEVATE AML, Tips for AML Patient Self-Advocacy /by Kara RayburnElevate | Expert Advice for Accessing Quality AML Care and Treatment Resource Guide
/in Acute Myeloid Leukemia, AML Access & Early Detection, AML Access & Early Detection Guide, AML Elevate, AML Elevate Guides, AML Newly Diagnosed, AML Programs, AML Resource ND, AML Resources TC, AML Treatment & Clinical Trials, AML Treatment & Clinical Trials Guide, AML Treatments and Clinical Trials, ELEVATE AML, Understanding AML Treatments and Treatment Decisions /by Kara RayburnSmall Words, Big Differences: Best Practices in Supportive Care for Patients With AML
/in Acute Myeloid Leukemia, AML Newly Diagnosed, AML Programs, AML Resource ND, AML Resource WPS, AML Resources TC, AML Treatments and Clinical Trials, AML Wellness & Support, AML Wellness & Support Video, AML Whole Patient Support, Art Flatau /by Kara RayburnBlogs
Informed and [ACT]IVATED Decision-Making in Acute Myeloid Leukemia Care
/in [ACT]IVATED AML, [ACT]IVATED AML Resources, Acute Myeloid Leukemia, AML Activated, AML Activated Resource Guides, AML Blog ND, AML Newly Diagnosed, AML Programs, AML Programs New /by Kara RayburnFLT3 Inhibitors for AML Update
/in Acute Myeloid Leukemia, AML Blog ND, AML Blog TC, AML Newly Diagnosed, AML Treatments and Clinical Trials, Art Flatau, Empowerment Lead Content, PEN Blog /by Art FlatauOlutasidenib for Relapsed or Refractory Acute Myeloid Leukemia with IDH1 Mutation
/in Acute Myeloid Leukemia, AML Blog ND, AML Blog TC, AML Newly Diagnosed, AML Treatments and Clinical Trials, Empowerment Lead Content, PEN Blog /by Art FlatauPodcasts
![[ACT]IVATED Program Logo](https://powerfulpatients.org/wp-content/uploads/Program-page-image-option-1.png "[ACT]IVATED Program Logo")
AML Clinical Trials | When to Consider This Treatment Option
/in Acute Myeloid Leukemia, AML Elevate, AML Elevate Treatment, AML Newly Diagnosed, AML Programs, AML Treatment & Clinical Trials, AML Treatment & Clinical Trials Video, AML Treatments and Clinical Trials, AML Video ND, AML Video TC, ELEVATE AML, Understanding AML Treatments and Treatment Decisions /by Kara RayburnEmerging AML Treatment Options | Inhibitor Therapies
/in Acute Myeloid Leukemia, AML Elevate, AML Elevate Treatment, AML Newly Diagnosed, AML Programs, AML Treatment & Clinical Trials, AML Treatment & Clinical Trials Video, AML Treatments and Clinical Trials, AML Video ND, AML Video TC, ELEVATE AML, Understanding AML Treatments and Treatment Decisions /by Kara RayburnAML Gene Mutations | Emerging Targeted Therapies in Development
/in Acute Myeloid Leukemia, AML Diagnosis & Testing, AML Diagnosis & Testing Video, AML Elevate, AML Elevate Treatment, AML Newly Diagnosed, AML Programs, AML Treatments and Clinical Trials, AML Video ND, AML Video TC, ELEVATE AML, Understanding AML Treatments and Treatment Decisions /by Kara Rayburn